The Supreme Court yesterday dismissed three writ petitions filed seeking to nullify the order issued by the Colombo High ...

Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive ...